Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution
 Back to Profile

Elizabeth Blair

Concepts (341)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Squamous Cell
19
2019
1002
1.730
 Why?
Head and Neck Neoplasms
24
2017
972
1.680
 Why?
Salivary Gland Neoplasms
5
2019
57
1.490
 Why?
Carcinoma, Mucoepidermoid
2
2019
15
1.470
 Why?
Chemoradiotherapy
14
2022
290
1.140
 Why?
Neoplasm Recurrence, Local
12
2019
1149
1.010
 Why?
Oropharyngeal Neoplasms
6
2022
118
0.920
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2022
2240
0.920
 Why?
Mouth Neoplasms
7
2018
173
0.800
 Why?
Paranasal Sinus Diseases
2
2018
23
0.790
 Why?
Gene Rearrangement
2
2019
167
0.770
 Why?
Papillomavirus Infections
5
2022
196
0.770
 Why?
Neoplasm Grading
1
2019
317
0.710
 Why?
Laryngeal Diseases
2
2015
15
0.700
 Why?
Nose Diseases
1
2017
10
0.690
 Why?
Nose Neoplasms
1
2017
31
0.690
 Why?
Maxillary Sinus
2
2018
26
0.660
 Why?
Nasal Cavity
1
2017
90
0.660
 Why?
Trans-Activators
1
2019
427
0.630
 Why?
Paranasal Sinus Neoplasms
1
2016
22
0.610
 Why?
Aspergillosis
1
2016
45
0.600
 Why?
Cementoma
1
2015
2
0.600
 Why?
Mandibular Neoplasms
1
2015
25
0.590
 Why?
Sarcoidosis
1
2015
88
0.550
 Why?
Papillomaviridae
4
2022
141
0.550
 Why?
Laryngeal Neoplasms
5
2017
82
0.540
 Why?
Sjogren's Syndrome
3
2009
28
0.510
 Why?
Salivary Glands, Minor
2
2009
10
0.500
 Why?
Middle Aged
43
2022
24750
0.480
 Why?
Aged, 80 and over
21
2020
6383
0.460
 Why?
Otolaryngology
1
2012
38
0.450
 Why?
Airway Management
1
2012
33
0.450
 Why?
Female
51
2022
43278
0.440
 Why?
Humans
68
2022
80834
0.420
 Why?
Adult
39
2022
25137
0.410
 Why?
Placenta
1
2011
196
0.400
 Why?
Aged
34
2020
17903
0.390
 Why?
Anesthesiology
1
2012
157
0.390
 Why?
Quinazolines
4
2012
213
0.390
 Why?
Male
48
2022
40407
0.380
 Why?
Induction Chemotherapy
6
2022
140
0.380
 Why?
Disease-Free Survival
15
2020
1157
0.360
 Why?
Neck
2
2020
88
0.340
 Why?
Head
2
2020
115
0.330
 Why?
Hydroxyurea
9
2012
228
0.330
 Why?
Radiotherapy, Intensity-Modulated
5
2016
167
0.320
 Why?
Clinical Competence
1
2012
684
0.310
 Why?
Radiotherapy Dosage
11
2020
463
0.300
 Why?
Warts
2
2019
11
0.300
 Why?
Fluorouracil
9
2012
537
0.290
 Why?
Tongue Neoplasms
4
2018
51
0.280
 Why?
Nasopharyngeal Neoplasms
2
2016
44
0.280
 Why?
Diagnosis, Differential
4
2017
1546
0.280
 Why?
Alphapapillomavirus
2
2021
38
0.260
 Why?
Treatment Outcome
17
2022
7653
0.260
 Why?
Antineoplastic Agents
6
2012
2276
0.260
 Why?
Neoplasm Staging
12
2016
1872
0.240
 Why?
Paclitaxel
5
2022
455
0.240
 Why?
Laryngostenosis
1
2021
13
0.230
 Why?
Tracheal Stenosis
1
2021
22
0.230
 Why?
Carcinoma
2
2016
439
0.220
 Why?
Drug Monitoring
1
2022
109
0.220
 Why?
Carcinoma, Papillary, Follicular
1
2020
11
0.220
 Why?
DNA, Viral
1
2022
275
0.220
 Why?
Respiratory System
1
2021
112
0.210
 Why?
In Situ Hybridization, Fluorescence
2
2019
356
0.210
 Why?
ras Proteins
1
2020
128
0.200
 Why?
Smoking
3
2014
544
0.200
 Why?
Follow-Up Studies
13
2019
3717
0.200
 Why?
Proto-Oncogene Proteins B-raf
1
2020
132
0.200
 Why?
Lymph Nodes
2
2016
517
0.200
 Why?
Risk Factors
8
2019
5257
0.200
 Why?
Retrospective Studies
15
2018
7532
0.200
 Why?
Arteries
1
2020
174
0.200
 Why?
Practice Guidelines as Topic
2
2017
1043
0.190
 Why?
Thyroid Neoplasms
2
2020
431
0.190
 Why?
Heterocyclic Compounds
1
2019
15
0.190
 Why?
Immunologic Deficiency Syndromes
1
2019
41
0.190
 Why?
Young Adult
6
2022
5780
0.190
 Why?
Radiation Dosage
1
2020
219
0.190
 Why?
Prognosis
9
2022
3603
0.190
 Why?
Lip
2
2009
14
0.190
 Why?
Bone Cysts, Aneurysmal
1
2018
7
0.190
 Why?
Receptors, CXCR4
1
2019
41
0.190
 Why?
Combined Modality Therapy
9
2016
1628
0.180
 Why?
Precancerous Conditions
2
2016
191
0.180
 Why?
Ubiquitin Thiolesterase
1
2018
54
0.180
 Why?
Orthodontic Appliances
1
2018
8
0.180
 Why?
Dental Alloys
1
2018
7
0.180
 Why?
Deglutition
3
2020
69
0.180
 Why?
Inflammation
2
2017
795
0.180
 Why?
Child
6
2019
6587
0.170
 Why?
Glottis
1
2017
9
0.170
 Why?
Adolescent
7
2022
8878
0.170
 Why?
Bone Marrow
1
2019
401
0.170
 Why?
Life Style
1
2018
182
0.160
 Why?
Hypopharyngeal Neoplasms
2
2011
15
0.160
 Why?
Fibrosis
1
2017
188
0.160
 Why?
Prospective Studies
7
2022
3961
0.160
 Why?
Transcriptome
1
2020
513
0.160
 Why?
Neoplasm Invasiveness
3
2016
512
0.150
 Why?
Fibroma, Ossifying
1
2015
5
0.150
 Why?
Time Factors
4
2019
5282
0.150
 Why?
Anticarcinogenic Agents
1
2016
72
0.150
 Why?
Guideline Adherence
1
2017
216
0.150
 Why?
Premedication
1
1995
57
0.150
 Why?
Pleural Neoplasms
1
2017
171
0.150
 Why?
Gene Expression Regulation, Neoplastic
1
2020
1164
0.140
 Why?
Cerebellopontine Angle
1
1994
6
0.140
 Why?
Ulnar Nerve
1
1994
6
0.140
 Why?
Neuroma, Acoustic
1
1994
16
0.140
 Why?
Tumor Virus Infections
1
2014
79
0.140
 Why?
Predictive Value of Tests
1
2019
1705
0.130
 Why?
Maximum Tolerated Dose
3
2012
259
0.130
 Why?
Neuromuscular Blocking Agents
1
1994
35
0.130
 Why?
Leukoplakia, Oral
1
2013
9
0.130
 Why?
Facial Nerve
1
1994
35
0.130
 Why?
Aminolevulinic Acid
1
2013
21
0.130
 Why?
Anti-Bacterial Agents
2
1999
796
0.130
 Why?
Photosensitizing Agents
1
2013
47
0.130
 Why?
Carboplatin
3
2022
267
0.130
 Why?
Biopsy
4
2009
1150
0.130
 Why?
Mouth
2
2011
51
0.120
 Why?
Monitoring, Intraoperative
1
1994
141
0.120
 Why?
Photochemotherapy
1
2013
96
0.120
 Why?
Pain
1
2015
354
0.120
 Why?
Radiation-Sensitizing Agents
1
2012
100
0.120
 Why?
Education, Medical, Graduate
1
2016
330
0.120
 Why?
Deglutition Disorders
2
2011
82
0.120
 Why?
Lymph Node Excision
1
2013
196
0.110
 Why?
Radiotherapy
2
2011
335
0.110
 Why?
Research Design
2
2013
545
0.110
 Why?
Survival Analysis
5
2018
1535
0.110
 Why?
Chemoradiotherapy, Adjuvant
1
2011
35
0.110
 Why?
Chemotherapy, Adjuvant
5
2012
445
0.110
 Why?
Protein Kinase Inhibitors
1
2016
532
0.110
 Why?
Tracheotomy
1
2011
17
0.110
 Why?
Organ Preservation
1
2011
71
0.110
 Why?
Survival Rate
4
2019
1852
0.110
 Why?
Speech
1
2010
72
0.100
 Why?
Brain Diseases
1
2011
184
0.100
 Why?
Genetic Predisposition to Disease
1
2019
2168
0.100
 Why?
Vocal Cords
1
2009
18
0.100
 Why?
Airway Obstruction
1
2011
112
0.100
 Why?
Agammaglobulinemia
1
2010
21
0.100
 Why?
Quality of Life
3
2012
1335
0.100
 Why?
Developmental Disabilities
1
2011
176
0.100
 Why?
Emergency Medical Services
1
2012
177
0.100
 Why?
Vascular Endothelial Growth Factor A
2
2009
368
0.100
 Why?
Kaplan-Meier Estimate
4
2013
868
0.090
 Why?
Cohort Studies
5
2018
2627
0.090
 Why?
Radiotherapy, High-Energy
1
2008
50
0.090
 Why?
United States
6
2018
6156
0.090
 Why?
Confidence Intervals
4
2018
227
0.090
 Why?
Enteral Nutrition
2
2020
103
0.090
 Why?
Neck Dissection
4
2010
70
0.090
 Why?
Myelitis, Transverse
1
2008
9
0.090
 Why?
Submandibular Gland Diseases
1
2008
9
0.090
 Why?
Genomics
1
2014
631
0.090
 Why?
Neoplasms, Second Primary
1
2011
247
0.090
 Why?
Military Personnel
1
2009
76
0.090
 Why?
Neoadjuvant Therapy
2
2012
265
0.090
 Why?
Neuromyelitis Optica
1
2008
16
0.090
 Why?
Skin
1
2012
540
0.090
 Why?
Aortic Aneurysm
1
1988
81
0.090
 Why?
Fatal Outcome
2
2019
290
0.080
 Why?
Risk Assessment
5
2016
2205
0.080
 Why?
Taxoids
1
2007
125
0.080
 Why?
Sinus Thrombosis, Intracranial
1
2006
11
0.080
 Why?
DNA
1
2012
1253
0.080
 Why?
Tinnitus
1
2006
19
0.080
 Why?
Headache
1
2006
67
0.080
 Why?
Incidence
3
2018
1593
0.080
 Why?
Prodrugs
2
1996
47
0.080
 Why?
Drug Administration Schedule
4
2016
926
0.070
 Why?
Infant, Newborn
1
2011
2352
0.070
 Why?
Dose-Response Relationship, Drug
3
2019
1991
0.070
 Why?
Antibodies, Monoclonal
2
2010
1466
0.070
 Why?
Drug Therapy, Combination
3
1999
969
0.070
 Why?
Cisplatin
2
2022
559
0.070
 Why?
Gastroesophageal Reflux
2
2009
110
0.070
 Why?
Pregnancy
1
2011
2717
0.070
 Why?
Adenocarcinoma
1
2011
1132
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2017
99
0.070
 Why?
Radiotherapy, Adjuvant
3
2010
295
0.060
 Why?
Internship and Residency
1
2012
887
0.060
 Why?
Tomography, X-Ray Computed
2
2011
2479
0.060
 Why?
Remission Induction
2
2016
690
0.060
 Why?
Retreatment
2
2012
106
0.060
 Why?
Immunohistochemistry
3
2017
1766
0.060
 Why?
Pulmonary Surgical Procedures
1
2021
8
0.060
 Why?
Alcohol Drinking
2
2018
273
0.060
 Why?
Gene Expression Profiling
2
2020
1322
0.060
 Why?
Receptor, Endothelin A
1
2021
22
0.060
 Why?
Clinical Trials, Phase II as Topic
2
2013
166
0.060
 Why?
Endothelial Growth Factors
1
2001
56
0.060
 Why?
Respiratory Function Tests
1
2021
145
0.060
 Why?
Lymphokines
1
2001
108
0.060
 Why?
Constriction, Pathologic
1
2021
208
0.050
 Why?
Periodontal Diseases
1
2000
9
0.050
 Why?
Lymphoid Tissue
1
2000
55
0.050
 Why?
Radiography
2
2014
842
0.050
 Why?
Hyperplasia
1
2000
146
0.050
 Why?
Bronchoscopy
1
2021
146
0.050
 Why?
Antibodies, Monoclonal, Humanized
3
2011
891
0.050
 Why?
Disease Progression
2
2017
1430
0.050
 Why?
Clindamycin
2
1999
15
0.050
 Why?
Cefuroxime
2
1996
3
0.050
 Why?
Feasibility Studies
1
2022
729
0.050
 Why?
Tonsillectomy
1
1999
27
0.050
 Why?
Patient-Centered Care
1
2021
175
0.050
 Why?
Carcinoma, Papillary
1
2001
182
0.050
 Why?
Benzylamines
1
2019
14
0.050
 Why?
Neoplasms, Squamous Cell
1
2019
19
0.050
 Why?
Aortic Rupture
2
1990
51
0.050
 Why?
Bone Marrow Examination
1
2019
51
0.050
 Why?
Patient Care Team
1
2021
260
0.050
 Why?
Antibiotic Prophylaxis
1
1999
79
0.050
 Why?
Primary Myelofibrosis
1
2019
52
0.050
 Why?
Evidence-Based Medicine
1
2021
436
0.050
 Why?
Oral Health
1
2018
10
0.050
 Why?
Double-Blind Method
3
2016
1829
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
11
0.040
 Why?
Myoepithelioma
1
2017
11
0.040
 Why?
Metals
1
2018
87
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2017
23
0.040
 Why?
Laryngectomy
1
2017
25
0.040
 Why?
Surgical Wound Infection
2
1999
183
0.040
 Why?
Multivariate Analysis
2
2011
968
0.040
 Why?
Parotid Gland
1
2017
33
0.040
 Why?
Statistics, Nonparametric
2
2009
312
0.040
 Why?
Adenocarcinoma, Clear Cell
1
2017
58
0.040
 Why?
Oncogene Proteins, Fusion
1
2017
118
0.040
 Why?
Mutation
2
2020
3737
0.040
 Why?
Probability
2
2008
346
0.040
 Why?
Otitis Media
1
1996
13
0.040
 Why?
Translocation, Genetic
1
2017
260
0.040
 Why?
Loss of Heterozygosity
1
2016
84
0.040
 Why?
Otitis Media with Effusion
1
1995
7
0.040
 Why?
Pyrazoles
1
2017
162
0.040
 Why?
Analgesics, Opioid
1
2020
373
0.040
 Why?
Cutaneous Fistula
1
1995
11
0.040
 Why?
Cellulitis
1
1995
22
0.040
 Why?
Cephalosporins
1
1995
39
0.040
 Why?
Pyridines
1
2017
300
0.040
 Why?
Dissection
1
1995
46
0.040
 Why?
Magnetic Resonance Imaging
3
2017
3149
0.040
 Why?
Human papillomavirus 18
1
2014
15
0.040
 Why?
Costs and Cost Analysis
1
1995
149
0.030
 Why?
Human papillomavirus 16
1
2014
36
0.030
 Why?
Protein Interaction Maps
1
2014
49
0.030
 Why?
Sex Factors
1
2018
1046
0.030
 Why?
Drug Costs
1
1995
60
0.030
 Why?
Hospital Costs
1
1995
99
0.030
 Why?
Administration, Oral
1
2016
700
0.030
 Why?
Electromyography
1
1994
169
0.030
 Why?
Drug Resistance, Neoplasm
1
2017
553
0.030
 Why?
Amoxicillin-Potassium Clavulanate Combination
3
1999
4
0.030
 Why?
Clavulanic Acids
3
1999
4
0.030
 Why?
Societies, Medical
1
2017
558
0.030
 Why?
Amoxicillin
3
1999
14
0.030
 Why?
DNA Copy Number Variations
1
2014
174
0.030
 Why?
Multicenter Studies as Topic
1
2013
146
0.030
 Why?
Electric Stimulation
1
1994
365
0.030
 Why?
Age Factors
1
2018
1842
0.030
 Why?
Rabbits
1
1994
706
0.030
 Why?
Platinum
1
2012
58
0.030
 Why?
Aorta, Abdominal
2
1990
60
0.030
 Why?
Phenotype
1
2019
2226
0.030
 Why?
Organ Sparing Treatments
1
2011
34
0.030
 Why?
Length of Stay
1
1995
680
0.030
 Why?
Supraglottitis
1
2011
3
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2012
183
0.030
 Why?
Glutamates
1
2011
88
0.030
 Why?
Leucovorin
1
2010
208
0.030
 Why?
Clinical Trials, Phase I as Topic
1
2011
145
0.030
 Why?
Antimetabolites, Antineoplastic
1
2012
240
0.030
 Why?
Osteoradionecrosis
1
2010
14
0.030
 Why?
Guanine
1
2011
200
0.030
 Why?
Antineoplastic Agents, Phytogenic
1
2012
291
0.030
 Why?
Interferon-alpha
1
2010
234
0.030
 Why?
Postoperative Period
1
2010
300
0.020
 Why?
Laryngoscopy
1
2009
36
0.020
 Why?
Deoxycytidine
1
2011
225
0.020
 Why?
Siblings
1
2010
102
0.020
 Why?
Camptothecin
1
2010
193
0.020
 Why?
Treatment Failure
1
2010
290
0.020
 Why?
Dose-Response Relationship, Radiation
1
2009
199
0.020
 Why?
Transforming Growth Factor alpha
1
2009
51
0.020
 Why?
Postoperative Complications
1
1999
2189
0.020
 Why?
Syndrome
1
2010
426
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2009
79
0.020
 Why?
Chi-Square Distribution
1
2009
369
0.020
 Why?
Bone Marrow Cells
1
2010
251
0.020
 Why?
Arteriosclerosis
1
1988
158
0.020
 Why?
Hypersensitivity
1
2009
140
0.020
 Why?
Recombinant Proteins
1
2010
1021
0.020
 Why?
Bacterial Infections
1
2010
222
0.020
 Why?
Neoplasm Metastasis
1
2012
1021
0.020
 Why?
Lymphatic Metastasis
1
2009
492
0.020
 Why?
Regression Analysis
1
2009
599
0.020
 Why?
Autoantibodies
1
2008
250
0.020
 Why?
Cranial Sinuses
1
2006
13
0.020
 Why?
Odds Ratio
1
2008
653
0.020
 Why?
Blood Vessel Prosthesis
1
1988
223
0.020
 Why?
Neoplasm Proteins
1
2010
529
0.020
 Why?
Comorbidity
1
2009
894
0.020
 Why?
Endothelium, Vascular
1
1988
426
0.020
 Why?
Cerebrovascular Circulation
1
2006
208
0.020
 Why?
Prevalence
1
2008
1220
0.020
 Why?
Coronary Artery Disease
1
1988
355
0.020
 Why?
Preoperative Care
1
2006
400
0.020
 Why?
Signal Transduction
1
2014
3177
0.020
 Why?
Algorithms
1
2011
1766
0.010
 Why?
Registries
1
2006
659
0.010
 Why?
Asthma
1
2009
851
0.010
 Why?
Vascular Endothelial Growth Factors
1
2001
57
0.010
 Why?
Case-Control Studies
1
2006
1763
0.010
 Why?
Ticarcillin
1
1999
2
0.010
 Why?
Mouthwashes
1
1999
5
0.010
 Why?
Ampicillin
1
1999
28
0.010
 Why?
Administration, Topical
1
1999
95
0.010
 Why?
Injections, Intravenous
1
1999
254
0.010
 Why?
Infant
2
1996
3007
0.010
 Why?
Child, Preschool
2
1996
3642
0.010
 Why?
Pilot Projects
1
1999
798
0.010
 Why?
Suspensions
1
1996
8
0.010
 Why?
Animals
2
1994
26044
0.010
 Why?
Bacteria
1
1999
451
0.010
 Why?
Acute Disease
1
1996
833
0.010
 Why?
Back Pain
1
1990
35
0.010
 Why?
Hematoma
1
1990
91
0.010
 Why?
6-Ketoprostaglandin F1 alpha
1
1988
6
0.010
 Why?
Polytetrafluoroethylene
1
1988
69
0.010
 Why?
Microscopy, Electron, Scanning
1
1988
155
0.010
 Why?
Jugular Veins
1
1988
69
0.010
 Why?
Omentum
1
1988
67
0.010
 Why?
Microcirculation
1
1988
102
0.010
 Why?
Dogs
1
1988
785
0.010
 Why?
Aorta
1
1988
294
0.010
 Why?
Thrombosis
1
1988
258
0.000
 Why?
Blair's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (341) concept(s)
_
Co-Authors Expand Description
See all (44) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_